Category Venues

TTIP: EU Commissioner Points Finger At US Secrecy, Investor-State Provisions

A number of problems with investor-state dispute settlement (ISDS) were outlined by legal experts during a 1 April hearing in Brussels of the International Trade Committee (INTA) of the European Parliament in its last session before the European elections. And the European trade commissioner said he would agree to open the Transatlantic Trade and Investment Partnership (TTIP) talks and to drop ISDS from the TTIP if the United States would agree.

US Trade Barriers Report Highlights IPRs Among Top Concerns

The United States Trade Representative’s annual report on barriers to US exports contains many references to intellectual property rights issues. These include latest topics of debate such as the treatment of pharmaceutical patents in India, online piracy in Russia, and European-guided geographical indications laws in Latin America. It also highlights recent commitments by China on protection of pharmaceutical patents and trade secrets.

“Innocence of Muslims” Creates Copyright Controversy In US

When “Innocence of Muslims” first appeared online, the video provoked outrage among millions of Muslims around the world. Now the consternation has spread to many copyright experts, internet firms, news organisations, and entertainment companies, who assert that a recent 9th Circuit decision about the movie makes a major change in US copyright law, with terrible consequences for the internet, media, and free speech. Others state that the ruling makes no change at all in US law.

Alleged Leaked EU Analysis Sheds Light On TTIP Negotiations On IP

An alleged leaked analysis by the European Union provides insight into the intellectual property section of the draft Transatlantic Trade and Investment Partnership (TTIP) with the United States. And separately, the US International Trade Commission released a report on trade barriers that US small businesses perceive in exporting to Europe.

Alternative Therapies, Incentive Models Eyed For Antibiotic Resistance

As bacteria become more and more resistant to existing medicines, product pipelines are drying up. A solution may lie in a forgotten therapy developed in 1917, the use of which has been restricted to certain parts of Eastern Europe ever since the discovery and universal use of antibiotics. But business models and intellectual property regimes need to change to provide incentives for research and development in this area.